PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-Feb-2023 Kuros Biosciences Announces Changes to Executive Management Team Kuros Biosciences AG
16-Feb-2023 Lonza Completes Expansion of Conjugation Facility in Visp (CH) Lonza Group AG
16-Feb-2023 LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership for N-LIfT Allogeneic Neutrophil Based Cell Therapy B3C newswire
16-Feb-2023 Medartis 2022 full-year results presentation Medartis Holding AG
16-Feb-2023 Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose Marinomed Biotech AG
16-Feb-2023 Cosmo Pharmaceuticals reports record results for 2022, preliminary results exceeding guidance, increased dividend distribution and 2023 guidance Cosmo Pharmaceuticals N.V.
16-Feb-2023 saniva diagnostics receives approval from the US FDA for its medical product NeuroMex Xlife Sciences AG
16-Feb-2023 Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia Newron Pharmaceuticals S.p.A.
15-Feb-2023 Explore The Latest Trends At PHARMAP 2023 PHARMAP 2023
14-Feb-2023 Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO ABIVAX
14-Feb-2023 ACI Group launches Oomph to help solve data visibility challenges for SMEs ACI Group
14-Feb-2023 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2022 Sosei Heptares
14-Feb-2023 Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China Clover Biopharmaceuticals, Ltd.
14-Feb-2023 Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD Elanix Biotechnologies AG
14-Feb-2023 APONTIS PHARMA accelerates expansion of Single Pill portfolio with second of three in-licensing deals planned for 2023 APONTIS PHARMA AG
14-Feb-2023 Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa Relief Therapeutics Holding SA
13-Feb-2023 Douglas GmbH: Release of results for the 1st quarter 2022/23 (ending 31 December 2022) on 17 February 2023 Douglas GmbH
10-Feb-2023 CureVac Announces Closing of $250 million Follow-on Public Offering of Common Shares CureVac
10-Feb-2023 Weekly Pharma & Life Science News Round-Up: 6th February – 10th February 2023 PharmiWeb.Jobs
10-Feb-2023 Biotest AG: Biotest Supervisory Board appoints new Management Board member Biotest AG